Market Cap
$7,077,589,533
Enterprise Value
$8,842,989,533
Average Volume
$3,182,657
BRUKER CORP - BRKR
$46.48
-1.55
(-3.23%)
Valuation & Solvency
P/Tangible Book
2.89
P/E
-357.45
P/S
2.06
EV/EBITDA
31.02
EV/Sales
2.57
EV/FCF
-834.24
Dividend Yield
0.43%
Payout Ratio
-115.66%
Total Debt
$2,030,500,000
Cash & Marketable Securities
$295,000,000
Quick Ratio
0.91
Debt/Equity
0.82
Net Debt/EBITDA
6.19
Interest Coverage Ratio
0.99
About
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Beta
1.17
Company Description
▶
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.